ArticleThe Journal of clinical investigation2026
FBXW5 blunts RIGI/MDA5/IFN signaling to drive immune evasion and chemo-immune resistance in triple-negative breast cancer models.
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.